Edgewise Therapeutics, Inc. (EWTX)
39.59
-0.43
(-1.07%)
USD |
NASDAQ |
Oct 07, 16:00
39.59
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics Price : 39.59 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 40.66 | 41.03 | 39.34 | 40.02 | 1.625M |
| Oct 05, 2026 | 41.55 | 41.79 | 39.98 | 40.30 | 1.634M |
| Oct 02, 2026 | 41.01 | 41.94 | 40.42 | 41.40 | 1.460M |
| Oct 01, 2026 | 40.39 | 41.46 | 39.86 | 40.48 | 1.287M |
| Sep 30, 2026 | 39.49 | 42.12 | 38.89 | 40.60 | 1.678M |
| Sep 29, 2026 | 39.53 | 39.58 | 38.51 | 39.19 | 1.920M |
| Sep 28, 2026 | 39.12 | 40.10 | 39.12 | 39.79 | 2.984M |
| Sep 25, 2026 | 41.59 | 41.99 | 38.57 | 39.34 | 2.488M |
| Sep 24, 2026 | 40.28 | 41.94 | 39.74 | 41.16 | 1.379M |
| Sep 23, 2026 | 44.41 | 44.41 | 39.82 | 41.05 | 2.607M |
| Sep 22, 2026 | 44.99 | 45.99 | 44.39 | 44.51 | 2.091M |
| Sep 21, 2026 | 45.70 | 45.98 | 44.09 | 44.64 | 1.178M |
| Sep 18, 2026 | 46.79 | 46.93 | 45.32 | 45.32 | 1.992M |
| Sep 17, 2026 | 46.51 | 48.51 | 45.51 | 46.94 | 2.408M |
| Sep 16, 2026 | 43.37 | 45.60 | 43.37 | 45.44 | 1.684M |
| Sep 15, 2026 | 44.69 | 45.02 | 42.61 | 43.63 | 2.970M |
| Sep 14, 2026 | 43.98 | 45.70 | 43.95 | 44.62 | 1.104M |
| Sep 11, 2026 | 43.54 | 44.80 | 42.90 | 44.40 | 1.404M |
| Sep 10, 2026 | 42.82 | 43.50 | 42.35 | 42.90 | 788589.0 |
| Sep 09, 2026 | 43.03 | 44.30 | 42.97 | 43.39 | 707901.0 |
| Sep 08, 2026 | 42.84 | 44.92 | 42.21 | 43.82 | 1.286M |
| Sep 04, 2026 | 41.73 | 43.38 | 41.60 | 43.07 | 826754.0 |
| Sep 03, 2026 | 42.32 | 43.00 | 41.40 | 41.95 | 976765.0 |
| Sep 02, 2026 | 42.61 | 43.94 | 40.76 | 41.98 | 1.004M |
| Sep 01, 2026 | 41.59 | 42.64 | 40.82 | 42.25 | 1.041M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.07 |
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| Arvinas, Inc. | 7.46 |
| Fulcrum Therapeutics, Inc. | 3.685 |
| Definium Therapeutics, Inc. | 35.10 |
Price Related Metrics
| PEG Ratio | -1.134 |
| Price to Book Value | 9.523 |
| Earnings Yield | -4.67% |
| Market Cap | 4.267B |
| PEGY Ratio | -1.134 |